Search Results

Display Settings
Results per page: 10
Sort By: Relevance
Filter
  • 1-10 of  12 results for ""Non-Muscle Invasive Bladder Neoplasms""

Your Filters

Subject : gemcitabine
Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Early experience with sequential intravesical gemcitabine and docetaxel for micropapillary variant non-muscle invasive bladder cancer.

  • Authors : Abou Chakra M; Department of Urology, University of Iowa, Iowa City, IA. Electronic address: .; McElree IM

Subjects: Deoxycytidine*/Deoxycytidine*/Deoxycytidine*/analogs & derivatives ; Deoxycytidine*/Deoxycytidine*/Deoxycytidine*/administration & dosage ; Deoxycytidine*/Deoxycytidine*/Deoxycytidine*/therapeutic use

  • Source: Urologic oncology [Urol Oncol] 2024 Sep; Vol. 42 (9), pp. 289.e13-289.e21. Date of Electronic Publication: 2024 May 24.Publisher: Elsevier Country of Publication: United States NLM ID: 9805460 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Editorial & Opinion

Alternative instillation techniques of sequential intravesical gemcitabine and docetaxel for non-muscle-invasive bladder cancer.

  • Authors : McElree IM; Department of Urology, University of Iowa, Iowa, IA, USA.; Mott SL

Subjects: Deoxycytidine*/Deoxycytidine*/Deoxycytidine*/analogs & derivatives ; Deoxycytidine*/Deoxycytidine*/Deoxycytidine*/administration & dosage ; Docetaxel*/Docetaxel*/Docetaxel*/administration & dosage

  • Source: BJU international [BJU Int] 2024 Jun; Vol. 133 (6), pp. 671-673. Date of Electronic Publication: 2023 Oct 26.Publisher: Blackwell Science Country of Publication: England NLM ID: 100886721 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Induction and maintenance of sequential intravesical gemcitabine/docetaxel for intermediate and high-risk non-muscle invasive bladder cancer with different dosage protocols.

  • Authors : Ben-David R; Department of Urology, Icahn School of Medicine at Mount Sinai, The Milton and Carroll Petrie, New York, NY, USA. .; Department of Urology, Ichan School of Medicine at Mount Sinai, Tisch Cancer Institute, 1425 Madison Avenue, New York, NY, USA. .

Subjects: Deoxycytidine*/Deoxycytidine*/Deoxycytidine*/analogs & derivatives ; Deoxycytidine*/Deoxycytidine*/Deoxycytidine*/administration & dosage ; Docetaxel*/Docetaxel*/Docetaxel*/administration & dosage

  • Source: World journal of urology [World J Urol] 2024 May 11; Vol. 42 (1), pp. 315. Date of Electronic Publication: 2024 May 11.Publisher: Springer International Country of Publication: Germany NLM ID: 8307716 Publication Model: Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Comparing efficacy and safety of in-house gemcitabine to mitomycin for bladder instillation in intermediate-risk NMIBC.

  • Authors : Abou Chaaya C; Service d'urologie et chirurgie de la transplantation, hospices civils de Lyon, hôpital Édouard-Herriot, Lyon, France; Service d'urologie, hospices civils de Lyon, hôpital Lyon Sud, Lyon, France

Subjects: Gemcitabine* ; Deoxycytidine*/Deoxycytidine*/Deoxycytidine*/analogs & derivatives ; Deoxycytidine*/Deoxycytidine*/Deoxycytidine*/administration & dosage

  • Source: The French journal of urology [Fr J Urol] 2024 Dec; Vol. 34 (13), pp. 102699. Date of Electronic Publication: 2024 Jul 20.Publisher: Elsevier Masson SAS Country of Publication: France NLM ID: 9918752079106676 Publication Model: Print-Electronic Cited Medium: Internet

Record details

Read More Add to Saved list
×
Academic Journal

Cost-effectiveness analysis of different treatment modalities in BCG-unresponsive NMIBC.

  • Authors : Rieger C; Department of Urology, Urologic Oncology, Robot-Assisted and Specialized Urologic Surgery, University of Cologne, Cologne, Germany.; Schlüchtermann J

Subjects: Cost-Benefit Analysis* ; Urinary Bladder Neoplasms*/Urinary Bladder Neoplasms*/Urinary Bladder Neoplasms*/drug therapy ; Urinary Bladder Neoplasms*/Urinary Bladder Neoplasms*/Urinary Bladder Neoplasms*/economics

  • Source: BJU international [BJU Int] 2024 Oct; Vol. 134 (4), pp. 582-588. Date of Electronic Publication: 2024 Mar 16.Publisher: Blackwell Science Country of Publication: England NLM ID: 100886721 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Sequential Intravesical Chemotherapy for Treatment Naïve, High-Risk Non-Muscle Invasive Bladder Cancer: Oncologic Outcomes, Tolerance, and Comparison to Contemporary Controls.

  • Authors : Refugia JM; Department of Urology, Atrium Health Wake Forest Baptist, Winston-Salem, NC. Electronic address: .; Roebuck E

Subjects: Urinary Bladder Neoplasms*/Urinary Bladder Neoplasms*/Urinary Bladder Neoplasms*/drug therapy ; Urinary Bladder Neoplasms*/Urinary Bladder Neoplasms*/Urinary Bladder Neoplasms*/pathology ; BCG Vaccine*/BCG Vaccine*/BCG Vaccine*/administration & dosage

  • Source: Urology [Urology] 2024 Oct; Vol. 192, pp. 61-66. Date of Electronic Publication: 2024 Jun 19.Publisher: Elsevier Science Country of Publication: United States NLM ID: 0366151 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Chemoresistance-motility signature of molecular evolution to chemotherapy in non-muscle-invasive bladder cancer and its clinical implications.

  • Authors : Jeong MS; Department of Biomedical Sciences, Dong-A University, Busan, 49315, South Korea; Research Center, Dongnam Institute of Radiological & Medical Sciences (DIRAMS), Busan, 46033, South Korea.

Subjects: Urinary Bladder Neoplasms*/Urinary Bladder Neoplasms*/Urinary Bladder Neoplasms*/drug therapy ; Urinary Bladder Neoplasms*/Urinary Bladder Neoplasms*/Urinary Bladder Neoplasms*/genetics ; Urinary Bladder Neoplasms*/Urinary Bladder Neoplasms*/Urinary Bladder Neoplasms*/pathology

  • Source: Cancer letters [Cancer Lett] 2025 Feb 01; Vol. 610, pp. 217339. Date of Electronic Publication: 2024 Nov 26.Publisher: Elsevier Science Ireland Country of Publication: Ireland NLM ID: 7600053 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Prognostic role of the neutrophil/lymphocyte ratio in high-risk BCG-naïve non-muscle-invasive bladder cancer treated with intravesical gemcitabine/docetaxel.

  • Authors : Chakra MA; Department of Urology, University of Iowa Hospitals and Clinics, Iowa City, IA, USA.; Lassila R

Subjects: Urinary Bladder Neoplasms*/Urinary Bladder Neoplasms*/Urinary Bladder Neoplasms*/drug therapy ; Urinary Bladder Neoplasms*/Urinary Bladder Neoplasms*/Urinary Bladder Neoplasms*/pathology ; Urinary Bladder Neoplasms*/Urinary Bladder Neoplasms*/Urinary Bladder Neoplasms*/blood

  • Source: BJU international [BJU Int] 2025 Jan; Vol. 135 (1), pp. 125-132. Date of Electronic Publication: 2024 Jul 31.Publisher: Blackwell Science Country of Publication: England NLM ID: 100886721 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Intravesical Gemcitabine for Non-Muscle Invasive Bladder Cancer after Bacillus Calmette-Guerin Treatment Failure: A Prospective Study.

  • Authors : Mirzaee E; Department of Radiation Oncology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.; Novin K

Subjects: Urinary Bladder Neoplasms*/Urinary Bladder Neoplasms*/Urinary Bladder Neoplasms*/drug therapy ; Urinary Bladder Neoplasms*/Urinary Bladder Neoplasms*/Urinary Bladder Neoplasms*/pathology ; Gemcitabine*

  • Source: Asian Pacific journal of cancer prevention : APJCP [Asian Pac J Cancer Prev] 2024 Sep 01; Vol. 25 (9), pp. 3173-3177. Date of Electronic Publication: 2024 Sep 01.Publisher: Asian Pacific Organization for Cancer Prevention Country of Publication: Thailand NLM ID: 101130625 Publication Model: Electronic Cited Medium:

Record details

Read More Add to Saved list
×
Academic Journal

Short-term outcomes of intravesical gemcitabine for non-muscle-invasive bladder cancer after recent approval for use in Korea.

  • Authors : Kim GK; Department of Urology, Urological Science Institute, Yonsei University College of Medicine, Seoul, Korea.; Jo YH

Subjects: Urinary Bladder Neoplasms*/Urinary Bladder Neoplasms*/Urinary Bladder Neoplasms*/pathology ; Urinary Bladder Neoplasms*/Urinary Bladder Neoplasms*/Urinary Bladder Neoplasms*/drug therapy ; Urinary Bladder Neoplasms*/Urinary Bladder Neoplasms*/Urinary Bladder Neoplasms*/mortality

  • Source: Investigative and clinical urology [Investig Clin Urol] 2024 Sep; Vol. 65 (5), pp. 435-441.Publisher: Korean Urological Association Country of Publication: Korea (South) NLM ID: 101674989 Publication Model: Print Cited Medium: Internet

Record details

Read More Add to Saved list
×
  • 1-10 of  12 results for ""Non-Muscle Invasive Bladder Neoplasms""